ABL Diagnostics S.A Press Releases - EIN Presswire - Press Release Distribution Service

Published on June 25, 2025 - 16:12 GMT

ABL Diagnostics announces the payment of its first dividend for the 2024 financial year

ABL Diagnostics announces its first dividend for 2024 since the 2022 merger that led activity in the field of genotyping diagnostics of infectious diseases ABL Diagnostics SA (ENX:ABLD) WOIPPY, MOSELLE, FRANCE, June 25, 2025 /⁨EINPresswire.com⁩/ -- The …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on June 4, 2025 - 06:00 GMT

ABL Diagnostics to Present Breakthrough Scientific Data at the European Meeting on HIV & Hepatitis 2025

Featuring New Advances in Automated Bioinformatics and HIV Drug Resistance Detection Using Next-Generation Sequencing WOIPPY, FRANCE, June 4, 2025 /⁨EINPresswire.com⁩/ -- ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed leader in …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on May 28, 2025 - 06:00 GMT

ABL Diagnostics Expands Verification of DeepChek® on Additional MGI NGS Platforms to Enhance Microbiology Genotyping

Now Offering Native Library Preparation Kits and Workflow Automation for MGI Instruments WOIPPY, FRANCE, May 28, 2025 /⁨EINPresswire.com⁩/ -- ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed leader in molecular diagnostics, is proud …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on May 21, 2025 - 06:00 GMT

ABL Diagnostics Successfully Verifies DeepChek® Assays & Software on Illumina’s MiSeq™ i100 & MiSeqDx Platforms

WOIPPY, FRANCE, May 21, 2025 /⁨EINPresswire.com⁩/ -- ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed leader in molecular diagnostics, is proud to announce the successful verification of its DeepChek® Assays and Software Suite on …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on May 7, 2025 - 10:57 GMT

ABL Diagnostics to Increase Net Accounting Income Fivefold by 2024

A positive and increasing net accounting income in 2024, confirming ABL Diagnostics' ability to consolidate its historical activity ABL Diagnostics SA (EPA:ABLD) WOIPPY, MOSELLE, FRANCE, May 7, 2025 /⁨EINPresswire.com⁩/ -- ABL Diagnostics is a French …

Distribution channels: Business & Economy, Companies ...

Published on April 22, 2025 - 06:00 GMT

Advanced Biological Laboratories (ABL) S.A Inks Licensing Agreement with the Institut Pasteur for HPV RNA-Seq Technology

HPV Transcriptome as a Game-Changing Biomarker for Detection, Genotyping, and Monitoring of HPV-Associated Cervical High-Grade Cytology LUXEMBOURG, LUXEMBOURG, April 22, 2025 /⁨EINPresswire.com⁩/ -- Advanced Biological Laboratories (ABL), a diagnostics …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on April 2, 2025 - 06:00 GMT

ABL Diagnostics Signs Exclusive Distribution Agreement with Genient to Expand Microbiology Genotyping in India

WOIPPY, FRANCE, April 2, 2025 /⁨EINPresswire.com⁩/ -- ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed leader in molecular diagnostics, is pleased to announce an exclusive distribution agreement with Genient Tech Private Ltd. (https …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on March 17, 2025 - 07:00 GMT

ABL Diagnostics Signs Exclusive Distribution Agreement with Riken Genesis to Expand Microbiology Genotyping in Japan

WOIPPY, FRANCE, March 17, 2025 /⁨EINPresswire.com⁩/ -- ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed leader in molecular diagnostics, is pleased to announce an exclusive distribution agreement with Riken Genesis Co., Ltd. (https …

Distribution channels: Business & Economy, Companies ...

Published on February 4, 2025 - 06:30 GMT

ABL Diagnostics will Develop and Market a Full Range of PCR Testing Products Acquired from its Parent Company

ABL Diagnostics will start the production and commercialization of new UltraGene products based on PCR tests as recently announced by ABL Luxembourg ABL Diagnostics SA (EPA:ABLD) WOIPPY, MOSELLE, FRANCE, February 4, 2025 /⁨EINPresswire.com⁩/ -- ABL …

Distribution channels: Business & Economy, Companies ...

Published on February 3, 2025 - 18:52 GMT

ABL Inks Know-How License and Transfer Agreement for the Fast Track Diagnostics PCR Portfolio from Siemens Healthineers

ABL and affiliates plan to start the production and commercialization of new UltraGene products based on PCR tests previously supplied by Fast Track Diagnostics ABL Diagnostics SA (FR001400AHX6:ABLD) LUXEMBOURG VILLE, LUXEMBOURG, February 3, 2025 /⁨ …

Distribution channels: Business & Economy, Companies ...

Published on September 23, 2024 - 06:00 GMT

AdvancedDx Biological Laboratories USA Inc. and Complete Genomics LLC to co-market NGS microbiology solution in the U.S.

NEWBURYPORT, MA, UNITED STATES, September 23, 2024 /⁨EINPresswire.com⁩/ -- AdvancedDx Biological Laboratories USA Inc., an affiliate of ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed company that develops molecular biology assays …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on August 21, 2024 - 06:00 GMT

ABL Diagnostics continues its surveillance of SARS-CoV-2 variants and prepares for any resurgence of COVID-19 outbreaks

WOIPPY, FRANCE, August 21, 2024 /⁨EINPresswire.com⁩/ -- ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed company that develops molecular biology assays and software for microbiology laboratories today announced its DeepChek® offer …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on July 16, 2024 - 06:00 GMT

ABL Diagnostics expands its network of exclusive distributors and appoints INTERLUX OÜ in Estonia

WOIPPY, FRANCE, July 16, 2024 /⁨EINPresswire.com⁩/ -- ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed company that develops molecular biology assays and software for microbiology laboratories is pleased to announce today the …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on June 10, 2024 - 06:00 GMT

ABL Diagnostics Deeply Involved to Support Fight Against RSV Infection

WOIPPY, FRANCE, June 10, 2024 /⁨EINPresswire.com⁩/ -- ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed company that develops molecular biology assays and software for microbiology laboratories is pleased to announce the involvement …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on May 22, 2024 - 06:00 GMT

ABL Diagnostics Showcases Clinical Genotyping Scientific Communications at the European Meeting on HIV and Hepatitis

WOIPPY, FRANCE, May 22, 2024 /⁨EINPresswire.com⁩/ -- ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed company that develops molecular biology assays and software for microbiology laboratories is participating to the European Meeting …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on April 24, 2024 - 14:40 GMT

ABL DIAGNOSTICS: LIQUIDITY CONTRACT WITH ALLINVEST SECURITIES

ABL DIAGNOSTICS (ABLD) has announced the signing of a liquidity contract with ALLInvest Securities, effective from the morning of 24.04.2024. ABL Diagnostics SA (EPA:ABLD) WOIPPY, FRANCE, April 24, 2024 /⁨EINPresswire.com⁩/ -- ABL DIAGNOSTICS (ticker …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...

Published on April 23, 2024 - 16:00 GMT

ABL DIAGNOSTICS, MISE EN PLACE D’UN CONTRAT DE LIQUIDITE AVEC ALLINVEST SECURITIES

ABL DIAGNOSTICS (ABLD) annonce avoir signé un contrat de liquidité avec la société ALLInvest Securities, qui prendra effet le 24/04/2024 au matin. ABL Diagnostics SA (EPA:ABLD) WOIPPY, FRANCE, April 23, 2024 /⁨EINPresswire.com⁩/ -- ABL DIAGNOSTICS ( …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...